Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 4.15% vs 3.19% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 16.22% vs 34.19% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 40.68% vs 10.23% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 21.74% vs 14.49% in Mar 2024
Compare Profit and Loss Results of Medico Remedies
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
145.00
5.00
3.45%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
150.00
145.00
5.00
3.45%
Expenditure (Ex Depriciation)
Stock Adjustments
-5.00
6.00
-11.00
-183.33%
Raw Materials Consumed
113.00
74.00
39.00
52.70%
Power & Fuel Cost
2.00
7.00
-5.00
-71.43%
Employee Cost
6.00
21.00
-15.00
-71.43%
Operating Expenses
7.00
14.00
-7.00
-50.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
3.00
3.00
100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
135.00
134.00
1.00
0.75%
Operating Profit (PBDIT) excl Other Income
15.00
11.00
4.00
36.36%
Other Income
2.00
2.00
0.00
0.00%
Operating Profit (PBDIT)
17.00
13.00
4.00
30.77%
Interest
1.00
2.00
-1.00
-50.00%
Profit before Depriciation and Tax
16.00
11.00
5.00
45.45%
Depreciation
3.00
4.00
-1.00
-25.00%
Profit Before Taxation & Exceptional Items
13.00
6.00
7.00
116.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
4.00
9.00
225.00%
Provision for Tax
3.00
0.00
3.00
0%
Profit After Tax
10.00
4.00
6.00
150.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
32.00
-47.00
79.00
168.09%
Profit Available for appropriations
42.00
-42.00
84.00
200.00%
Appropriations
42.00
-42.00
84.00
200.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.22
1.76
-0.54
-30.68%
Profit And Loss - Net Sales
Net Sales 150.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.15% vs 3.19% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.22% vs 34.19% in Mar 2024
Profit And Loss - Interest
Interest 1.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.68% vs 10.23% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 10.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.74% vs 14.49% in Mar 2024
